BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Beckler DR, Elwasila S, Ghobrial G, Valentine JF, Naser SA. Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn’s disease. World J Gastroenterol 2008; 14(17): 2723-2730 [PMID: 18461657 DOI: 10.3748/wjg.14.2723]
URL: https://www.wjgnet.com/1007-9327/full/v14/i17/2723.htm
Number Citing Articles
Wei Jing, Yu Pang, Zhaojing Zong, Jing Wang, Ru Guo, Fengmin Huo, Guanglu Jiang, Yifeng Ma, Hairong Huang, Naihui Chu. Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis IsolatesFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01768
Gaurav Agrawal, Annabel Clancy, Roy Huynh, Thomas Borody. Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case seriesGut Pathogens 2020; 12(1) doi: 10.1186/s13099-020-00355-8
Gaurav Agrawal, John Aitken, Harrison Hamblin, Michael Collins, Thomas J. Borody. Putting Crohn’s on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn’s DiseaseDigestive Diseases and Sciences 2021; 66(2): 348 doi: 10.1007/s10620-020-06653-0
Lynne V McFarland. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008World Journal of Gastroenterology 2008; 14(17): 2625-2629 doi: 10.3748/wjg.14.2625
Daniel Wibberg, Marian Price-Carter, Christian Rückert, Jochen Blom, Petra Möbius. Complete Genome Sequence of Ovine Mycobacterium avium subsp. paratuberculosis Strain JIII-386 (MAP-S/type III) and Its Comparison to MAP-S/type I, MAP-C, and M. avium Complex GenomesMicroorganisms 2020; 9(1): 70 doi: 10.3390/microorganisms9010070
Ellen S. Pierce, Paul Barkhaus, Morgan Beauchamp, Mark Bromberg, Gregory T. Carter, Jill Goslinga, David Greeley, Sky Kihuwa-Mani, Gleb Levitsky, Isaac Lund, Christopher McDermott, Gary Pattee, Kaitlyn Pierce, Meraida Polak, Dylan Ratner, Paul Wicks, Richard Bedlack. ALSUntangled #66: antimycobacterial antibiotics.Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2023; 24(5-6): 539 doi: 10.1080/21678421.2022.2104650
Rodrick J. Chiodini, William M. Chamberlin, Jerzy Sarosiek, Richard W. McCallum. Crohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?Critical Reviews in Microbiology 2012; 38(1): 52 doi: 10.3109/1040841X.2011.638273
Vinicius Calado Nogueira de Moura, Minh-Vu H Nguyen, Joshua J Hunkins, Charles L Daley, Reeti Khare. In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022Journal of Antimicrobial Chemotherapy 2023; 78(12): 2849 doi: 10.1093/jac/dkad317
Barbara A. Brown-Elliott, Kevin A. Nash, Richard J. Wallace. Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous MycobacteriaClinical Microbiology Reviews 2012; 25(3): 545 doi: 10.1128/CMR.05030-11
M. Griffiths. Foodborne Pathogens2009; : 1060 doi: 10.1533/9781845696337.3.1060
Radka Pribylova, Lucie Kubickova, Vladimir Babak, Ivo Pavlik, Petr Kralik. Effect of short- and long-term antibiotic exposure on the viability of Mycobacterium avium subsp. paratuberculosis as measured by propidium monoazide F57 real time quantitative PCR and cultureThe Veterinary Journal 2012; 194(3): 354 doi: 10.1016/j.tvjl.2012.05.002
Anindita Banerjee, Mistu Karmakar, Saubashya Sur. Understanding the bacteria in Mycobacterium avium complex (MAC) from a bioinformatic perspective – a reviewActa Biologica Szegediensis 2024; 67(2): 203 doi: 10.14232/abs.2023.2.203-220
Oren Ledder, Dan Turner. Antibiotics in IBD: Still a Role in the Biological Era?Inflammatory Bowel Diseases 2018; 24(8): 1676 doi: 10.1093/ibd/izy067